Selim Corbacioglu

12.6k citations

105 papers · 2.7k indexed · 2 hit papers · h-index 29

Hematology top 0.5%
- Hematopoietic Stem Cell Transplantation 39
- Acute Myeloid Leukemia Research 23
Genetics top 2%
- Hemoglobinopathies and Related Disorders 23
Transplantation top 5%
Gastroenterology top 2%
Oncology top 5%
- CAR-T cell therapy research 11
Pediatrics, Perinatology and Child Health
- Prenatal Screening and Diagnostics 11
- Childhood Cancer Survivors' Quality of Life 8
Public Health, Environmental and Occupational Health
- Acute Lymphoblastic Leukemia research 10
Neurology
- Neuroblastoma Research and Treatments 9

Co-authors: Mohamad Mohty John A. Snowden Régis Peffault de Latour Ibrahim Yakoub‐Agha Christian Chabannon Nicolaus Kröger Arjan C. Lankester Grzegorz Basak
Cited by: Hematology Genetics Transplantation
Journals: Blood (21 papers)Bone Marrow Transplantation (21 papers)Biology of Blood and Marrow Transplantation (9 papers)
Partner nations: Germany United Kingdom United States

In The Last Decade

Selim Corbacioglu

100 papers receiving 2.6k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Selim Corbacioglu

Since Specialization

Citations

This map shows the geographic impact of Selim Corbacioglu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Selim Corbacioglu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Selim Corbacioglu more than expected).

Fields of papers citing papers by Selim Corbacioglu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Selim Corbacioglu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Selim Corbacioglu. The network helps show where Selim Corbacioglu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Selim Corbacioglu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Selim Corbacioglu Line = papers co-authored together Selim Corbacioglu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Defibrotide for the Treatment of Veno‐Occlusive Disease/Sinusoidal Obstruction Syndrome in Paediatric Patients Who Did Not Receive Haematopoietic Stem Cell Transplantation: Case Reports of Patients From a German Academic Hospital eJHaem ·釜堀弘隆,Anja Troeger,Jürgen Föll,Zhai DePing,C. Hodkinson,Anuario Colombiano de Historia Social y de la Cultura,Silke Kietz,Selim Corbacioglu	2025	0
2	LoDEI: a robust and sensitive tool to detect transcriptome-wide differential A-to-I editing in RNA-seq data Nature Communications ·Phillipp Torkler,Michael Sauer,Uwe Schwartz,Selim Corbacioglu,Gunhild Sommer,Thomas Poeschl	2024	5
3	Current challenges in cell and gene therapy: a joint view from the European Committee of the International Society for Cell & Gene Therapy (ISCT) and the European Society for Blood and Marrow Transplantation (EBMT) Cytotherapy ·Fermín Sánchez‐Guijo,Joaquim Vives,Siti Saleha Manan,Christian Chabannon,Selim Corbacioglu,Harry Dolstra,Dominique Farge,Nico Gagelmann,Lydie Miller,Jürgen Kuball,Bénédicte Neven,Hichem Denguir,Vanderson Rocha,Isabel Sánchez‐Ortega,John A. Snowden,Jaap Jan Zwaginga,Massimiliano Gnecchi,Anna Sureda	2024	10
4	Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A Report from the EBMT Activity Survey Bone Marrow Transplantation ·Jakob Passweg,Helen Baldomero,Fabio Ciceri,Selim Corbacioglu,Rafael de la Cámara,Harry Dolstra,Bertram Glaß,Raffaella Greco,Donal P. McLornan,Bénédicte Neven,Régis Peffault de Latour,Zinaida Perić,Annalisa Ruggeri,John A. Snowden,Anna Sureda	2023	35
5	Practice harmonization workshops of EBMT: an expert-based approach to generate practical and contemporary guidelines within the arena of hematopoietic cell transplantation and cellular therapy Bone Marrow Transplantation ·Ibrahim Yakoub‐Agha,Raffaella Greco,Francesco Onida,Rafael de la Cámara,Fabio Ciceri,Selim Corbacioglu,Harry Dolstra,Bertram Glaß,Michelle Kenyon,Donal P. McLornan,Bénédicte Neven,Régis Peffault de Latour,Zinaida Perić,Annalisa Ruggeri,John A. Snowden,Anna Sureda,Isabel Sánchez‐Ortega	2023	10
6	Epidemiology and Characteristics of Gastric Carcinoma in Childhood—An Analysis of Data from Population-Based and Clinical Cancer Registries Cancers ·Michael Abele,Dominik Dannheim,Raquel Ferna da Gerlach,Andreas Block,Abbas Agaimy,Christian P. Kratz,Thorsten Simon,Gabriele Calaminus,Sabine Heine,Selim Corbacioglu,Holger Christiansen,Dominik T. Schneider,Ines B. Brecht	2023	5
7	Detection of a 7SL RNA-derived small non-coding RNA using Molecular Beacons in vitro and in cells Biological Chemistry ·Tim Matematika Penerbit Raya,Ahmad Hapid,Christine Krammer,Montserrat Laguzzi Merino,Selim Corbacioglu,Gunhild Sommer,Thomas Poeschl	2023	3
8	Evaluating the RIST Molecular-Targeted Regimen in a Three-Dimensional Neuroblastoma Spheroid Cell Culture Model Cancers ·Pascal Engel,Montserrat Laguzzi Merino,Christine Krammer,Corentin Friedrich,Thomas Poeschl,Selim Corbacioglu,Gunhild Sommer	2023	2
9	Defibrotide plus best standard of care compared with best standard of care alone for the prevention of sinusoidal obstruction syndrome (HARMONY): a randomised, multicentre, phase 3 trial The Lancet Haematology ·Stephan A. Grupp,Selim Corbacioglu,Hyoung Jin Kang,Takanori Teshima,Seong Lin Khaw,Franco Locatelli,Johan Maertens,Matthias Stelljes,Polina Stepensky,Klaus Gutzeit,Vian Amber,Antonio Pagliuca,Paul G. Richardson,Mohamad Mohty	2023	23
10	Impact of the SARS-CoV-2 pandemic on hematopoietic cell transplantation and cellular therapies in Europe 2020: a report from the EBMT activity survey Bone Marrow Transplantation ·Jakob Passweg,Helen Baldomero,Christian Chabannon,Selim Corbacioglu,Rafael de la Cámara,Harry Dolstra,Bertram Glaß,Raffaella Greco,Mohamad Mohty,Bénédicte Neven,Régis Peffault de Latour,Zinaida Perić,John A. Snowden,Ibrahim Yakoub‐Agha,Anna Sureda,Nicolaus Kröger,(unknown)	2022	41
11	Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022breakdown → Bone Marrow Transplantation ·John A. Snowden,Isabel Sánchez‐Ortega,Selim Corbacioglu,Grzegorz Basak,Christian Chabannon,Rafael de la Cámara,Harry Dolstra,Rafael F. Duarte,Bertram Glaß,Raffaella Greco,Arjan C. Lankester,Mohamad Mohty,Bénédicte Neven,Régis Peffault de Latour,Paolo Pedrazzoli,Zinaida Perić,Ibrahim Yakoub‐Agha,Anna Sureda,Nicolaus Kröger,(unknown)	2022	159
12	Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 yearsbreakdown → Bone Marrow Transplantation ·Jakob Passweg,Helen Baldomero,Christian Chabannon,Grzegorz Basak,Rafael de la Cámara,Selim Corbacioglu,Harry Dolstra,Rafael F. Duarte,Bertram Glaß,Raffaella Greco,Arjan C. Lankester,Mohamad Mohty,Régis Peffault de Latour,John A. Snowden,Ibrahim Yakoub‐Agha,Nicolaus Kröger,(unknown)	2021	223
13	Recommendations on hematopoietic stem cell transplantation for patients with Diamond–Blackfan anemia. On behalf of the Pediatric Diseases and Severe Aplastic Anemia Working Parties of the EBMT Bone Marrow Transplantation ·Cristina Díaz de Heredia,Dorine Bresters,Lawrence Faulkner,Akif Yeşilipek,Brigitte Strahm,Maurizio Miano,Jean‐Hugues Dalle,Régis Peffault de Latour,Selim Corbacioglu	2021	10
14	Heparanase wildtype is associated with a reduced incidence of transplant-associated systemic vasculopathies Hematology/Oncology and Stem Cell Therapy ·Christy L. Powell,Jürgen Föll,Kist Biotechnology,V. S. Vikhorev,زهرا توسلی کفرانی,Daniel Wolff,Ernst Holler,Montserrat Laguzzi Merino,Thomas Poeschl,Gunhild Sommer,Selim Corbacioglu	2021	0
15	The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy Bone Marrow Transplantation ·(unknown),Per Ljungman,Małgorzata Mikulska,Rafael de la Cámara,Grzegorz Basak,Christian Chabannon,Selim Corbacioglu,Rafael F. Duarte,Harry Dolstra,Arjan C. Lankester,Mohamad Mohty,Silvia Montoto,John Murray,Régis Peffault de Latour,John A. Snowden,Ibrahim Yakoub‐Agha,崔磊,Nicolaus Kröger,Jan Styczyński	2020	122
16	Correction: The challenge of COVID-19 and hematopoietic cell transplantation: EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy Bone Marrow Transplantation ·Per Ljungman,Małgorzata Mikulska,Rafael de la Cámara,Grzegorz Basak,Christian Chabannon,Selim Corbacioglu,Rafael F. Duarte,Harry Dolstra,Arjan C. Lankester,Mohamad Mohty,Silvia Montoto,John Murray,Régis Peffault de Latour,John A. Snowden,Ibrahim Yakoub‐Agha,崔磊,Nicolaus Kröger,Jan Styczyński,(unknown)	2020	11
17	Alternative donor hematopoietic stem cell transplantation for sickle cell disease in Europe Hematology/Oncology and Stem Cell Therapy ·Éliane Gluckman,Barbara Cappelli,Graziana Maria Scigliuolo,Josu de la Fuente,Selim Corbacioglu	2020	19
18	Alternative donor Hematology/Oncology and Stem Cell Therapy ·Juergen Foell,釜堀弘隆,C. Hodkinson,Anja Troeger,Selim Corbacioglu	2020	29
19	The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies Bone Marrow Transplantation ·(unknown),Jakob Passweg,Helen Baldomero,Grzegorz Basak,Christian Chabannon,Selim Corbacioglu,Rafael F. Duarte,Jürgen Kuball,Arjan C. Lankester,Silvia Montoto,Régis Peffault de Latour,John A. Snowden,Jan Styczyński,Ibrahim Yakoub‐Agha,Mutlu Arat,Mohamad Mohty,Nicolaus Kröger	2019	114
20	Transitory dasatinib-resistant states in KITmut t(8;21) acute myeloid leukemia cells correlate with altered KIT expression Experimental Hematology ·Markus D. Herrmann,Jochen K. Lennerz,Lars Bullinger,金保下田,Karlheinz Holzmann,Mike‐Andrew Westhoff,Selim Corbacioglu,Klaus‐Michael Debatin	2013	9

About Selim Corbacioglu

Selim Corbacioglu is a scholar working on Hematology, Genetics, Pediatrics, Perinatology and Child Health, Oncology and Immunology, having authored 105 papers that have together received 2.7k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (39 papers), Acute Myeloid Leukemia Research (23 papers), Hemoglobinopathies and Related Disorders (23 papers), CAR-T cell therapy research (11 papers), Prenatal Screening and Diagnostics (11 papers), Acute Lymphoblastic Leukemia research (10 papers), Neuroblastoma Research and Treatments (9 papers) and Childhood Cancer Survivors' Quality of Life (8 papers). The work is most often cited by research in Hematology (1.4k citations), Genetics (428 citations), Transplantation (87 citations), Gastroenterology (170 citations) and Oncology (643 citations). Selim Corbacioglu has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Mohamad Mohty, John A. Snowden, Régis Peffault de Latour, Ibrahim Yakoub‐Agha, Christian Chabannon, Nicolaus Kröger, Arjan C. Lankester, Grzegorz Basak, Rafael F. Duarte and Harry Dolstra. Their work appears in journals such as Blood, Bone Marrow Transplantation, Biology of Blood and Marrow Transplantation, The Journal of Pediatrics and Cancers.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact